Skip to Content
Merck
CN

S8876

Sulfamerazine

ReagentPlus®, ≥99.0%

Synonym(s):

4-Amino-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide, N1-(4-Methylpyrimidin-2-yl)sulfanilamide

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C11H12N4O2S
CAS Number:
Molecular Weight:
264.30
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
204-866-2
Beilstein/REAXYS Number:
249133
MDL number:
Assay:
≥99.0%
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

product line

ReagentPlus®

assay

≥99.0%

SMILES string

Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1

InChI

1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)

InChI key

QPPBRPIAZZHUNT-UHFFFAOYSA-N

Legal Information

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany


Still not finding the right product?

Explore all of our products under Sulfamerazine


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral

Storage Class

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



A practical sulfenylation of 2,5-diketopiperazines.
K C Nicolaou et al.
Angewandte Chemie (International ed. in English), 51(3), 728-732 (2011-12-14)
Yi Li et al.
International journal of pharmaceutics, 415(1-2), 110-118 (2011-06-08)
The ability to detect and quantify polymorphism of pharmaceuticals is critically important in ensuring that the formulated product delivers the desired therapeutic properties because different polymorphic forms of a drug exhibit different solubilities, stabilities and bioavailabilities. The purpose of this
Florian M Koch et al.
Chemistry (Weinheim an der Bergstrasse, Germany), 17(13), 3679-3692 (2011-03-03)
The first catalytic asymmetric synthesis of β-sultones is reported. This development has enabled a rapid access to a number of highly enantioenriched biologically interesting sulfonyl and sulfinyl compound classes, which makes use of the inherent ring strain of the four-membered



Global Trade Item Number

SKUGTIN
S8876-50G04061836961121
S8876-250G04061836961107
S8876-500G04061836961114